期刊文献+

静脉栓塞的原发性和获得性因素研究现状 被引量:1

Progress in primary and acquired factors of venous thromboembolism
原文传递
导出
摘要 静脉栓塞发病率及病死率高,是临床常见疾病,及时正确地识别可改善预后,有时可预防其发生。全面而深入地了解静脉血栓形成的危险因素对于我们更好地识别及进一步预防或处理有重要意义。本文就目前静脉血栓形成的原发及获得性因素的研究现状进行综述。 Venous thromboembolism is a common disease with high morbidity and mortality. The prognosis of this disease can be improved through timely correct recognition, and sometimes it can be prevented. Hence,comprehensive and in-depth understanding of risk factors of venous thromboembolism is important for us to better identify and further prevent and treat the disease. In this paper, the current research status of primary and acquired factors of venous thromboembolism is reviewed.
作者 陈细细 柯蕾
出处 《国际呼吸杂志》 2015年第22期1751-1755,共5页 International Journal of Respiration
关键词 静脉栓塞 原发性因素 获得性因素 Venous thromboembolism Primary factors Acquired factors
  • 相关文献

参考文献2

二级参考文献40

  • 1于海东,郑红,齐华,连建华,贺颖,董子明.同型半胱氨酸代谢酶基因多态性与深静脉血栓的相关性研究[J].中华医学遗传学杂志,2006,23(6):635-639. 被引量:17
  • 2Stearns-Kurosawa DJ,Kurosawa S,Mollica JS,Ferrell GL,Esmon CT.The endothelial cell protein C receptor augments protein C activation by the thrombin-thrombomodulin complex.Proc Natl Acad Sci U S A 1996; 93:1021-1026.
  • 3Centelles MN,Puy C,López-Sagaseta J,Fukudome K,Montes R,Hermida J.Blocking endothelial protein C receptor (EPCR) accelerates thrombus development in vivo.Thromb Haemost 2010; 103:1239-1244.
  • 4Yamagishi K,Cushman M,Heckbert SR,Tsai MY,Folsom AR.Lack of association of soluble endothelial protein C receptor and PROCR 6936A/G polymorphism with the risk of venous thromboembolism in a prospective study.Br J Haematol 2009; 145:221-226.
  • 5Saposnik B,Reny JL,Gausem P,Emmerich J,Aiach M,Gandrille S.A haplotype of the EPCR gene is associated with increased plasma levels of sEPCR and is a candidate risk factor for thrombosis.Blood 2004; 103:1311-1318.
  • 6Medina P,Navarro S,Estellés A,Vayá A,Woodhams B,Mira Y,et al.Contribution of polymorphisms in the endothelial protein C receptor gene to soluble endothelial protein C receptor and circulating activated protein C levels,and thrombotic risk.Thromb Haemost 2004; 91:905-911.
  • 7Uitte de Willige S,van Marion V,Rosendaal FR,Vos HL,de Visser MC,Bertina RM.Haplotypes of the EPCR gene,plasma sEPCR levels and the risk of deep venous thrombosis.Thromb Haemost 2004; 2:1305-1310.
  • 8Villoutreix BO,Biota AM,Dahlback B.Structural prediction and analysis of endothelial cell protein C/activated protein C receptor.Protein Eng 1999; 12:833-840.
  • 9Qu D,Wang Y,Song Y,Esmon NL,Esmon CT.The Ser219→Gly dimorphism of the endothelial protein C receptor contributes to the higher soluble protein levels observed in individuals with the A3 haplotype.Thromb Haemost 2006; 4:229-235.
  • 10Stearns-Kurosawa DJ,Swindle K,D'Angelo A,Della Valle P,Fattorini A,Caron N,et al.Plasma levels of endothelial protein C receptor respond to anticoagulant treatment.Blood 2002; 99:526-530.

共引文献13

引证文献1

相关作者

内容加载中请稍等...

相关机构

内容加载中请稍等...

相关主题

内容加载中请稍等...

浏览历史

内容加载中请稍等...
;
使用帮助 返回顶部